ACTIVE

Clinitude

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-40 k €

+66.8% YoY

Gross margin

419,4 k €

-7.2% YoY

Equity

-374,8 k €

-11.9% YoY

Workforce

4,3 ETP

-30.6% YoY

What does Clinitude do?

Clinitude is a Private limited company incorporated in 2002. Its registered office is in Diepenbeek. It employs on average 4,3 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0478.640.857

Incorporation

24/10/2002

Legal form

Private limited company

Registered office

Agoralaan Abis
3590 Diepenbeek · FlandreSee on map

Contributed capital

68 600,00 €

Latest accounts

31/12/2025

Average workforce

4,3 ETP

Joint committees (2)

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	419,4 k €	-7.2%	451,8 k €	+7082%	-6,5 k €	-101%	532,6 k €	-24.4%	704,2 k €	+93.6%	363,7 k €	+46.9%	247,6 k €	-17.1%	298,7 k €	+97.8%	151 k €	-47.2%	285,9 k €	+185%	100,4 k €	-51.9%	208,7 k €	-8.2%	227,2 k €	+134%	97,1 k €	-39.7%	161,2 k €	-9.4%	177,9 k €	+12.2%	158,5 k €	-0.7%	159,6 k €	+163%	60,7 k €
EBITDA	-4,3 k €	+94.6%	-79,2 k €	+86.0%	-563,8 k €	-1754%	-30,4 k €	-107%	462,6 k €	+117%	212,7 k €	+49.5%	142,3 k €	-3.9%	148,2 k €	+163%	-235,1 k €	-613%	45,9 k €	+159%	-77,4 k €	-651%	14 k €	-67.1%	42,6 k €	+320%	-19,4 k €	-179%	24,6 k €	+754%	-3,8 k €	-148%	7,8 k €	-88.2%	66,7 k €	+339%	15,2 k €
Operating result	-11,8 k €	+87.3%	-93,4 k €	+84.1%	-585,7 k €	-1041%	-51,3 k €	-111%	449,3 k €	+119%	205,5 k €	+82.8%	112,4 k €	-22.2%	144,4 k €	+159%	-244,3 k €	-979%	27,8 k €	+130%	-93,4 k €	-1194%	8,5 k €	-76.3%	36 k €	+233%	-26,9 k €	-264%	16,5 k €	+219%	-13,8 k €	-1944%	-676,2 €	-101%	58,3 k €	+633%	8 k €
Net result	-40 k €	+66.8%	-120,5 k €	+79.9%	-598,5 k €	-913%	-59,1 k €	-119%	304 k €	+106%	147,8 k €	+45.5%	101,6 k €	-19.2%	125,8 k €	+148%	-260,4 k €	-1413%	19,8 k €	+122%	-91,8 k €	-3329%	2,8 k €	-90.5%	29,9 k €	+200%	-29,8 k €	-483%	7,8 k €	+141%	-18,9 k €	-137%	-8 k €	-123%	34,3 k €	+2718%	-1,3 k €
Balance sheet
Equity	-374,8 k €	-11.9%	-334,8 k €	-56.2%	-214,3 k €	-156%	384,3 k €	-13.3%	443,4 k €	+214%	141 k €	+2804%	-5,2 k €	+95.1%	-106,8 k €	+54.1%	-232,5 k €	-934%	27,9 k €	+247%	8 k €	-83.9%	49,9 k €	+6.0%	47 k €	+175%	17,1 k €	-63.5%	46,9 k €	+19.9%	39,1 k €	-32.6%	58 k €	-12.1%	66 k €	+108%	31,7 k €
Total assets	279,1 k €	-31.9%	409,6 k €	-19.7%	510 k €	-44.6%	920,9 k €	+28.2%	718,6 k €	+147%	290,9 k €	+51.3%	192,2 k €	+10.5%	173,9 k €	+72.1%	101,1 k €	-50.9%	206 k €	+55.9%	132,2 k €	+5.8%	125 k €	+16.6%	107,2 k €	+32.3%	81 k €	-21.0%	102,5 k €	+7.9%	95 k €	-21.9%	121,6 k €	-18.1%	148,6 k €	+98.2%	75 k €
Cash	21,8 k €	-72.9%	80,5 k €	-24.9%	107,3 k €	-71.7%	379,6 k €	+14.4%	331,9 k €	+349%	74 k €	-11.8%	83,8 k €	+54.0%	54,4 k €	+407%	10,7 k €	-63.9%	29,7 k €	+81.7%	16,3 k €	+76.7%	9,3 k €	-33.8%	14 k €	+357%	3,1 k €	-17.8%	3,7 k €	-52.2%	7,8 k €	-83.6%	47,4 k €	-36.0%	74 k €	+101%	36,8 k €
Debts	653,7 k €	-10.5%	730 k €	+5.4%	692,7 k €	+30.0%	532,8 k €	+94.0%	274,7 k €	+83.7%	149,5 k €	-22.5%	192,8 k €	-30.8%	278,6 k €	-12.5%	318,6 k €	+81.1%	175,9 k €	+41.9%	124 k €	+73.9%	71,3 k €	+89.0%	37,7 k €	-26.8%	51,6 k €	+2.2%	50,4 k €	-3.5%	52,3 k €	+2.2%	51,1 k €	-13.4%	59 k €	+36.5%	43,2 k €
Other
Workforce	4,3 ETP	-30.6%	6,2 ETP	-12.7%	7,1 ETP		–		–		–		–		–		–		4,5 ETP	+4.7%	4,3 ETP	+34.4%	3,2 ETP	-8.6%	3,5 ETP	+59.1%	2,2 ETP	-26.7%	3,0 ETP	-18.9%	3,7 ETP	+12.1%	3,3 ETP	+43.5%	2,3 ETP	+76.9%	1,3 ETP

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 8 ended

Active mandates

Nemax

Director · 0771.311.336

Represented by Sabrina Wijnen

Active

Ended mandates

Nemax

Director · since 05 août 2024 · 0771.311.336

Represented by Sabrina Wijnen

Ended

Nemax

Director · since 01 août 2021 · 0771.311.336

Represented by Gert Monnissen

Ended

SABRINA WIJNEN

Director · since 01 mars 2020

Ended

Gert Monnissen

Director · until 01 août 2021

Ended

At this address

Other companies at this address

Company	CBE no.
Bedal International● Active	0841.685.826
BIOCLUE● Active	0719.914.105
BIOKEY● Active	0719.913.808
BIOSTRAND● Active	0719.913.907
C-Path● Active	0762.683.482
FOx Biosystems● Bankrupt	0653.744.366
Highstar Engineering● Active	0685.983.703
IDEA FAMILY● Active	0719.674.177
NanoBiotech● Active	1023.651.490
Presscuff● Active	0800.361.153
Reprosci Biosciences● Active	1008.398.241
Sealantium Medical Belgium● Active	1012.599.727
SIMABS● Active	0732.709.096
Stichting Administratiekantoor Bedal International● Active	1011.224.604
StingOrg● Active	0804.587.383

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	27/08/2026	12/08/2025	18/11/2024	31/08/2023	31/08/2022	20/08/2021
General meeting	24/06/2026	25/06/2025	14/11/2024	28/06/2023	22/06/2022	23/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	24/06/2026	27/08/2026	Dutch	PDF
Abridged model	31/12/2024	25/06/2025	12/08/2025	Dutch	PDF
Abridged model	31/12/2023	14/11/2024	18/11/2024	Dutch	PDF
Micro model	31/12/2022	28/06/2023	31/08/2023	Dutch	PDF
Micro model	31/12/2021	22/06/2022	31/08/2022	Dutch	PDF
Micro model	31/12/2020	23/06/2021	20/08/2021	Dutch	PDF
Micro model	31/12/2019	24/06/2020	30/07/2020	Dutch	PDF
Micro model	31/12/2018	26/06/2019	30/08/2019	Dutch	PDF
Micro model	31/12/2017	27/06/2018	31/08/2018	Dutch	PDF
Abridged model	30/06/2016	30/12/2016	30/12/2016	Dutch	PDF
Abridged model	30/06/2015	26/12/2015	29/12/2015	Dutch	PDF
Abridged model	30/06/2014	26/12/2014	29/12/2014	Dutch	PDF
Abridged model	30/06/2013	27/12/2013	30/12/2013	Dutch	PDF
Abridged model	30/06/2012	28/12/2012	31/12/2012	Dutch	PDF
Abridged model	30/06/2011	30/12/2011	25/01/2012	Dutch	PDF
Abridged model	30/06/2010	31/12/2010	04/01/2011	Dutch	PDF
Abridged model	30/06/2009	26/12/2009	29/12/2009	Dutch	PDF
Abridged model	30/06/2008	26/12/2008	06/01/2009	Dutch	PDF
Abridged model	30/06/2007	28/12/2007	07/01/2008	Dutch	PDF
Abridged model	30/06/2006	29/12/2006	03/01/2007	Dutch	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 8 ended

Active mandates

Nemax

Director · 0771.311.336

Represented by Sabrina Wijnen

Active

Ended mandates

Nemax

Director · since 05 août 2024 · 0771.311.336

Represented by Sabrina Wijnen

Ended

Nemax

Director · since 01 août 2021 · 0771.311.336

Represented by Gert Monnissen

Ended

SABRINA WIJNEN

Director · since 01 mars 2020

Ended

Gert Monnissen

Director · until 01 août 2021

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Registered office24/08/2026
ZETEL
PDF
Mandates22/11/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates31/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/09/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/04/2020
ONTSLAGEN - BENOEMINGEN
PDF
Other05/07/2017
ALGEMENE VERGADERING - BOEKJAAR
PDF
Registered office01/06/2015
MAATSCHAPPELIJKE ZETEL - ADRESSEN ANDERS DAN MAATSCHAPPELIJKE ZETEL - DOEL - KAPITAAL - AANDELEN
PDF
Registered office01/12/2004
MAATSCHAPPELIJKE ZETEL
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-40 k €↑
2024
Annual accounts 2024-120,5 k €↑
2023
Annual accounts 2023-598,5 k €↓
2023
Name changeClinitude
2022
Annual accounts 2022-59,1 k €↓
2021
Annual accounts 2021304 k €↑
2021
Name changeNEW X
2020
Annual accounts 2020147,8 k €↑
2019
Annual accounts 2019101,6 k €↓
2018
Annual accounts 2018125,8 k €↑
2017
Annual accounts 2017-260,4 k €↓
2016
Annual accounts 201619,8 k €↑
2015
Annual accounts 2015-91,8 k €↓
2014
Annual accounts 20142,8 k €↓
2013
Annual accounts 201329,9 k €↑
2012
Annual accounts 2012-29,8 k €↓
2011
Annual accounts 20117,8 k €↑
2010
Annual accounts 2010-18,9 k €↓
2009
Annual accounts 2009-8 k €↓
2008
Annual accounts 200834,3 k €↑
2007
Annual accounts 2007-1,3 k €
24/10/2002
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Clinitude

Overview

What does Clinitude do?

Trend over 19 financial years

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline